Portfolio Lab

State Street(R) SPDR(R) S&P(R) Biotech ETF

  • ETF
  • Ticker XBI
  • NYSE

Performance, volatility and drawdowns of State Street(R) SPDR(R) S&P(R) Biotech ETF since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

XBIGlobal equities (VT)

$10,000 grew to $21,417. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −63.9% in 05/2022, measured from the peak in 02/2021. The old peak has not been reached again yet.

Factor profile

Monthly returns 12/2016 to 09/2026, measured against USA. The factors explain 65% of the variation.

Market
0.81
Size
1.04
Value
−0.47
Profitability
−0.73
Low investment
−0.05
Momentum
0.02

How to read this: XBI moves less than the stock market (USA): when the market rises by 1%, the ETF rises by 0.81% on average. The ETF leans towards small companies, highly valued growth stocks and less profitable companies.

A value of 1 for the market means: when the market rises by 1%, the ETF rises by 1% on average. The other values show the lean towards small, cheaply valued, profitable, conservatively investing and recently strong stocks; bold where it is clear. Calculated with the Fama and French factors and momentum.

Open in factor analysis

Annual returns

Best year 2020 at +48.3%, weakest 2022 at −25.9%. 6 of 9 full years were positive. * partial year.

Similar ETFs

Frequently asked questions

How has XBI performed since 11/2016?

$10,000 grew to $21,417 by 20 Nov 2026, which is +7.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is XBI?

Volatility was 26.6% per year, measured on monthly returns. The largest decline from a peak was −63.9%, with the low in 05/2022.

How does XBI compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, XBI returned +7.9% at 26.6%. The correlation of monthly returns was 0.61; 1 would mean they moved in lockstep.

What does XBI hold?

XBI holds 150 positions. The largest are Apogee Therapeutics Inc, Moderna Inc and Twist Bioscience Corp; the 10 largest together make up 13.3% of the fund (holdings as of 30 Jun 2026, according to the fund's filing with the SEC).

Which currency are the figures in?

In US dollars, the currency of the US listing.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI)